Cargando…
Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer
To determine the prognostic value of the timing of circulating breast tumour cell measurement during treatment, peripheral blood from 164 patients with breast disease was collected. Circulating tumour cells (CTCs) were enriched by using immunomagnetic nanospheres (IMNs) and were identified by using...
Autores principales: | Pang, Shuyun, Li, Hanjun, Xu, Shu, Feng, Liying, Ma, Xueping, Chu, Yanan, Zou, Bingjie, Wang, Shaohua, Zhou, Guohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241989/ https://www.ncbi.nlm.nih.gov/pubmed/34188122 http://dx.doi.org/10.1038/s41598-021-92876-8 |
Ejemplares similares
-
Molecular profiles of single circulating tumor cells from early breast cancer patients with different lymph node statuses
por: Pang, Shuyun, et al.
Publicado: (2022) -
Galectin‐3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2‐positive breast cancer cells
por: Chen, Yuqiu, et al.
Publicado: (2022) -
Point-of-care DNA testing by automatically and sequentially performing extraction, amplification and identification in a closed-type cassette
por: Dong, Tianhui, et al.
Publicado: (2021) -
Anionic liposomes prepared without organic solvents for effective siRNA delivery
por: Han, Xiu, et al.
Publicado: (2023) -
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin’s lymphoma
por: Pinochet, Pierre, et al.
Publicado: (2021)